Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators
Wojciech Solarek, Michał Koper, Sławomir Lewicki, et al.
Journal of Cell Communication and Signaling (2019) Vol. 13, Iss. 3, pp. 381-394
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Epidemiology of Renal Cell Carcinoma: 2022 Update
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 405
Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression
Li Gao, Xiang Zhong, Juan Jin, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 91
IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways
Wenpeng Cai, Yongfang Ma, Song Li, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Breast milk MSCs upregulated β-cells PDX1, Ngn3, and PCNA expression via remodeling ER stress /inflammatory /apoptotic signaling pathways in type 1 diabetic rats
Tarek Khamis, Abdelalim F. Abdelalim, Ahmed Saeed, et al.
European Journal of Pharmacology (2021) Vol. 905, pp. 174188-174188
Closed Access | Times Cited: 35
Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammation
Qin Yang, Hongmei Zang, Xing Tian, et al.
Phytomedicine (2021) Vol. 85, pp. 153541-153541
Closed Access | Times Cited: 34
Renal Cell Cancer and Obesity
Anna Gluba-Brzózka, Jacek Rysz, Janusz Ławiński, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3404-3404
Open Access | Times Cited: 22
Degenerative Disease Diagnosis and Analysis Based on Tissue Specificity of DNA Methylation
Jian Zhao, Wei Yao, Hanlin Gao, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 452-452
Open Access
Maximizing the Potential of Ketogenic Dieting as a Potent, Safe, Easy-to-Apply and Cost-Effective Anti-Cancer Therapy
Simeon Ikechukwu Egba, Catherine Daniel
Archives of Cancer Science and Therapy (2025) Vol. 9, Iss. 1, pp. 001-005
Open Access
The expression profiles of piRNAs and their interacting Piwi proteins in cellular model of renal development: Focus on Piwil1 in mitosis
Marek Kazimierczyk, Agnieszka Fedoruk‐Wyszomirska, Dorota Gurda, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 3, pp. 151444-151444
Open Access | Times Cited: 3
The Healing Capability of Clove Flower Extract (CFE) in Streptozotocin-Induced (STZ-Induced) Diabetic Rat Wounds Infected with Multidrug Resistant Bacteria
Rewaa Ali, Tarek Khamis, Gamal Enan, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2270-2270
Open Access | Times Cited: 15
Bacteriophage therapy as an alternative technique for treatment of multidrug-resistant bacteria causing diabetic foot infection
Amira Mohamed Ghanaim, Mohammed Abdulaziz Foaad, Eman Zakaria Gomaa, et al.
International Microbiology (2022) Vol. 26, Iss. 2, pp. 343-359
Open Access | Times Cited: 14
Identification of miRNA signatures for kidney renal clear cell carcinoma using the tensor-decomposition method
Ka‐Lok Ng, Y‐h. Taguchi
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 20
The Role of Metabolic Factors in Renal Cancers
Jacek Rysz, Beata Franczyk, Janusz Ławiński, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7246-7246
Open Access | Times Cited: 19
CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer
Mingdi Zhang, Kejin Wu, Maoli Wang, et al.
International Journal of Analytical Chemistry (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 12
Research progress on the correlation between obesity and the occurrence and development of kidney cancer: a narrative review
Le Kang, Xu Chen, Peng Qi, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 10, pp. 5678-5690
Open Access | Times Cited: 2
Targeting POLE2 Creates a Novel Vulnerability in Renal Cell Carcinoma via Modulating Stanniocalcin 1
Chuanjie Zhang, Yan Shen, Lili Gao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Chromosome‐level Asian elephant genome assembly and comparative genomics of long‐lived mammals reveal the common substitutions for cancer resistance
Xuanjing Li, Pengcheng Wang, Qi Pan, et al.
Aging Cell (2023) Vol. 22, Iss. 9
Open Access | Times Cited: 5
The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma
Yusri Dwi Heryanto, Seiya Imoto
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Integrated mendelian randomization analyses highlight AFF3 as a novel eQTL-mediated susceptibility gene in renal cancer and its potential mechanisms
Qiming Wang, Shaopeng Chen, Gang Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?
Fernando Bril, Alicia Elbert
Metabolism (2024), pp. 156066-156066
Closed Access | Times Cited: 1
High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study
Meng Chen, Chia-Wen Tsai, Wen-Shin Chang, et al.
Carcinogenesis (2021) Vol. 42, Iss. 6, pp. 826-830
Closed Access | Times Cited: 10
Introduction to DOK2 and its Potential Role in Cancer
Pei Sun, Ren‐Ke Li, Yingying Meng, et al.
Physiological Research (2021), pp. 671-685
Open Access | Times Cited: 10
Identification of prognostic factors for intrahepatic cholangiocarcinoma using long non-coding RNAs-associated ceRNA network
Zhichen Kang, Lixin Guo, Zhuo Zhu, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Establishment and Validation of a Machine Learning Prediction Model Based on Big Data for Predicting the Risk of Bone Metastasis in Renal Cell Carcinoma Patients
Chan Xu, Wencai Liu, Chengliang Yin, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 6
Post-transplant diabetes mellitus and renal cell cancer after renal transplantation
Esteban Porrini, Núria Montero, Juan Manuel Díaz, et al.
Nephrology Dialysis Transplantation (2022) Vol. 38, Iss. 6, pp. 1552-1559
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top